MENU
ALT
AS OF
Nov 13 closing price
Price
$4.06
Change
-$0.17 (-4.02%)
Capitalization
423.63M
132 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ALT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Altimmune (ALT) Earnings Date & Reports

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases... Show more

A.I. Advisor
published Earnings

ALT is expected to report earnings to rise 50.05% to -31 cents per share on March 26

Altimmune ALT Stock Earnings Reports
Q4'25
Est.
$-0.32
Q3'25
Beat
by $0.06
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.01
The last earnings report on November 06 showed earnings per share of -20 cents, beating the estimate of -27 cents. With 2.43M shares outstanding, the current market capitalization sits at 423.63M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ALT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALT showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ALT
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Miscellaneous Commercial Services
Address
910 Clopper Road
Phone
+1 240 654-1450
Employees
59
Web
https://www.altimmune.com